Press Release

Apr, 12 2023

CANON MEDICAL SYSTEMS CORPORATION, Koninklijke Philips N.V, and General Electric Company were dominating the Global Kidney Cancer Diagnostics Market in 2022

The Global Kidney Cancer Diagnostics Market is expected to grow with a CAGR of 6.4% in the forecast period of 2023 to 2030. The years considered for the study are as mentioned below.

Access Full Report @

The global kidney cancer diagnostics market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenarios.

The major players dealing in the market are engaged in developing and producing products utilized in the treatment, among others. The main applications for kidney cancer majorly lie in surgeries, medical treatments, and others.

CANON MEDICAL SYSTEMS CORPORATION is the market leader in the kidney cancer diagnostics market. The other players in this market are Koninklijke Philips N.V, General Electric Company, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Creative Diagnostics, Myriad Genetics, Inc., BD, QIAGEN, Illumina Inc., and Inviate Corporation, among others.


CANON MEDICAL SYSTEMS CORPORATION is headquartered in Tochigi Prefecture, Japan and was founded in 1930. The company is focused on delivering innovative imaging solutions and services to improve the quality of life for people.

The company provides product categories, which are Angiography, Computed Tomography, Magnetic Resonance, Ultrasound, X-Ray, Nuclear Medicine, Healthcare IT, and RE Amplifier Components. The market-focused category is Computed Tomography, Magnetic Resonance, and Ultrasound.

Subsidiaries include Canon Research Centre France S.A.S (France), Canon Marketing Japan Inc. (Japan), Canon Medical Systems USA, Inc. (USA), Canon France S.A.S. (France), and Canon Singapore Pte. Ltd. (Singapore), among others.

For Instance,

  • In July 2022, Canon Medical Systems USA Inc. announced the completion of the acquisition of NXC Imaging, a medical imaging equipment distributor and service provider located in Minnesota, U.S. This results in expanding the service outreach in the global market.

The company has a wide global presence across North America, South America, Europe, Asia-Pacific, the Middle East and Africa.

 Koninklijke Philips N.V.

Koninklijke Philips N.V. was founded in 1891 and headquartered in Amsterdam, Netherlands. The company focuses on the purpose of improving people’s health and well-being through meaningful innovation and giving clinicians the tools they need to make a precise diagnosis and deliver personalized treatment.

The company provides product categories, which are Breathing and respiratory care, Circular Edition systems, Computed Tomography Machines & Solutions, Customer Service Solutions, Diagnostic ECG, Diagnostic informatics, Emergency Care and Resuscitation Solutions, Enterprise telehealth portfolio, Hospital Respiratory Care, Image Guided Therapy, Mother & Child Care, MRI Systems & Solutions, Neurology, Oncology, Pathology, Patient Monitoring, Personal Health Programs, Radiation Oncology, Radiography | X-ray & Fluoroscopy Solutions, Sleep, Supplies and Accessories, Ultrasound, Ventilation CMF, Foot & Ankle, Hip, Joint Reconstruction, Knees, Shoulder, Spine, Trauma and Extremities, Trauma - Pediatrics segment is the market focused category. The market-focused category is Ultrasound.

For Instance,

  • In November 2022, Koninklijke Philips N.V. announced the global launch of a next-generation compact portable ultrasound solution at the Radiological Society of North America (RSNA) annual meeting to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients. It is portable and versatile with good image quality or performance. It is Compatible with Philips ultrasound systems Affiniti and EPIQ transducer. This has helped the company to expand its product portfolio.

The company has a wide global presence across Europe, Asia Pacific, America, the Middle East and Africa.

Kidney Cancer Diagnostics Market

General Electric Company

General Electric Company was founded in 1892 and is headquartered in Massachusetts, USA. The company focuses on creating a world where healthcare has no limits. Together, we are digitizing healthcare, driving productivity to improve the lives of patients, and creating meaningful efficiencies for providers, health systems, and researchers around the world.  The market-focused category is Imaging, Ultrasound.

The company provides product categories such as Imaging, Ultrasound, Anesthesia Delivery, Diagnostic ECG, Maternal & Infant Care, Patient Monitoring, Ventilators, Pharmaceutical Imaging Agents, Digital Solutions, Refurbished Systems, Parts and Accessories.

Subsidiaries include GE Aviation Systems (U.S.), GE Ventures (U.S.), GE Capital Rail Services (Netherlands), and GE HealthCare (U.S.), among others.

For Instance,

  • In October 2022, General Electric Company collaborated with several research institutes like the University of Cambridge Hospitals, Sophia Genetics, and earlier with Optellum to use imaging data in collaboration with Artificial intelligence. This will help to reduce the diagnosing time of several cancers and help to provide personalized care to patients. This has helped the company to widen its horizons in cancer diagnostics.

The company has a wide global presence across North America, Europe, Asia-Pacific, South America, the Middle East and Africa.

Client Testimonials